López-Íñiguez A, Mijangos-Méndez JC

Idioma: Español
Referencias bibliográficas: 35
Paginas: 141-149
Archivo PDF: 557.05 Kb.

RESUMEN

La Unidad de Cuidados Intensivos (UCI) es un servicio de alta especialidad en donde se trata a los pacientes críticamente enfermos. El paciente crítico es aquel que presenta un padecimiento agudo potencialmente reversible que pone en riesgo su vida, por lo que requiere de un estrecho monitoreo y supervisión por la grave disfunción orgánica que presenta. Dada la condición de este paciente, demanda una visión integral distinta al resto de pacientes en un hospital, ya que su sola condición representa un reto para el médico y es un predisponente para la aparición de entidades específicas propias, tales como polineuropatía del paciente crítico y la hiperglucemia por estrés, entre otras. Estas entidades obedecen a una interacción compleja de factores que se presentan en el organismo durante los estados agudos de estrés. La identificación oportuna y tratamiento de estos padecimientos permite mejorar el pronóstico para el paciente y disminuir su mortalidad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.Hermans G., De Jonghe B., Bruyninckx F., Van den Berghe G. Clinical review: Critical illness polyneuropathy and miopathy. Critical Care 2008, 12:238.

2. 2.Garnacho-Montero J., Madrazo-Osuna J., García-Garmendia J.L., Ortiz- Leyba C., Jiménez-Jiménez F.J., Barrero-Almodóvar A. et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001, 27: 1288-1296.

3. 3.Locke G.R., Pemberton J.H., Phillips S.F. American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology 2000; 119: 1761-6.

4. Masri Y., Abubaker J., Ahmed R. Prophylactic use of laxative for constipation in critically ill patients. Annals of Thoracic Medicine. 2010; Vol.

5. 5 Issue 4. 5.Marra A., Edmond M., Wenzel R., Bearman G. Hospital acquired Clostridium Difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. Biomed Central Infectious Diseases 2007; 42: 2334-2340.

6. 6.Cohen S., Gerding D., Johnson S., Kelly C., Loo V., McDonald C., Pepin J., Wilcox M. Clinical Practice Guidelines for Clostridium difficile. Infectious Diseases Society of America 2010; 5: 1086/ 651706.

7. Erstad B., Barletta J., Jacobi J., Killian A., Kramer K., Martin S.. Survey of stress ulcer prophylaxis. Critical Care. 2009; 6: 145-149.

8. 8.Young P., Hwang J., Bae Sung P., Chul Hyun K.. The risk factores and outcome of acute kidney injury in the Intensive Care Units. The Korean Journal of Internal Medicine. 2010; 25.2.181.

9. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Critical Care 2006; 10: R73.

10. Aldawood A. Outcome and prognostic factors of critically ill patients with acute renal failure requiring continuous renal replacement therapy. Saudi Journal of Kidney Diseases and Transplantation. 2010; 21: 1106-1110.

11. Bello G., Ceaichisciuc S., Silva S., Antonelli M. The role of thyroid dysfunction in the critical ill: a review of the literature. Minerva Medica 2010; 76: 919-928.

12. Pingitore A., Galli E., Barison A., Lervasi A. Scarlatinni M., Nucci D., et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low T3 syndrome: a randomized, placebo-controlled study. J Clin Endoc Met 2008; 93: 1351-8.

13. Novitzky D., Cooper D.K., Morrell D., Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988; 45: 32-36.

14. Manzanares W., Aramendi I. Hiperglucemia de estrés y su control con insulina en el paciente critico: evidencia actual. Medicina Intensiva. 2010; 34: 273-281.

15. Kreutziger J., Wenzel V., Kurz A., Constantinescu M.A. Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients. Intensive Care Medicine. 2009; 35: 1234-1239.

16. Yu W.K., Li W.Q., Li A., Li J.S. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and contra-regulatory hormone concentrations. World Journal of Gastroenterology. 2003; 9: 1824-1827.

17. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive Insulin therapy in the critically ill patients. N Eng J Med 2001; 345: 1359-1367.

18. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive Insulin therapy in the medical ICU. N Eng J Med 2006; 354: 449-461.

19. Dellinger R.P., Levy M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Intensive Care Medicine 2008; 34: 17-60.

20. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V. et al. Intensive versus conventional glucose control in critically ill patients. N Eng JMed 2009; 360: 1283-1297

21. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. American Thoracic Society Board of Directors and the Infectious Diseases Society of America Committee. Am J Resp Cri Care Med. 2004; 171: 388-416.

22. Chastre J., Wolff M., Fagon J.Y., Chevret S., Thomas F., Wermert D., Clementi E., Gonzalez J., Jusserand D., Asfar P., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 2003; 290: 2588-2598.

23. File TM. Community-acquired pneumonia. Lancet 2003; 362: 1991-2001.

24. Craven D.E., Goularte T.A., Make B.J. Contaminated condensate in mechanical ventilator circuits: a risk factor for nosocomial pneumonia?. Am Rev Resp Dis 1984; 129: 625-628.

25. Craven D.E., Lichtenberg D.A., Goularte T.A., Make B.J., McCabe W.R. Contaminatedd medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am J Med 1984; 77: 834-838.

26. Drakulovic M.B., Torres A., Bauer T.T., Nicolas J.M., Nogue S., Ferrer M.. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 1999; 354: 1851- 1858.

27. Smet A.G.M.G., Kluytsmans J.A.J.W., Cooper B.S., Mascini E.M., Benus R.F.J., van der Werf T.S., et al. Decontamination of the Digestive tract and Oropharynx in ICU patients. N Eng J Med 2009; 360: 20-31.

28. Cheng Mei Shi, Dong Xin Wang, Kai-Sheng Chen, Xi uGu. Incidence and risk factors of delirium in critically ill patients after non-cardiac surgery. Chinese Medical Journal 2010; 123:993-999.

29. McIntosh T.K., Bush H.L., Yeston N.S., Grasberger R., Palter M., et al. Betaendorphin, cortisol and postoperative delirium: a preliminaey report. Psychoneuroendocrinology 1985; 10: 303-313.

30. Ziegler T.R. Parental Nutrition in the Critically Ill Patient. N Eng J Med 2009; 361: 1088-97.

31. Oliveira G., Dias C., Pelosi P. et al. Understanding the mechanisms of glutamine action in critically ill patients. Anals da Academia Brasileira de Ciencias. 2010; 82: 417-430.

32. Meduri G.U., Rocco P.R., Annane D., Sinclair S.E.. Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome. Expert Review of Respiratory Medicine. 2006; 4: 201-210.

33. Tang B.M., Craig J.C., Eslick G.D., Seppelt I., McLean I. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med2009; 37: 1594-1603.

34. Malhotra D., Guroo S., Qazi S., Gupta S. Randomized Comparative Efficacy of Dexamethasone to Prevent Postextubation Upper Airway Complications in Children and Adults in ICU. Indian Journal of Anaesthesia 2009; 53: 442-449.

35. Sprung C.L., Annane D., Keh D., Moreno R., Singer M., Freivogel K., et al. Hydrocortisone therapy for patients with septic shock. N Eng J Med 2008; 358: 111-124.